TrialAnnals of oncology : official journal of the European Society for Medical Oncology2009

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study.

A Goy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.